BusinessWeek blurb on Genentech's robust growth High earnings (2.50 EPS for 2007) High growth (28% out to 2010) Low PEG, low forward P/E <A HREF="http://www.businessweek.com/magazine/content/06_31/b3995125.htm?chan=search" target="_blank">http://www.businessweek.com/magazine/content/06_31/b3995125.htm?chan=search</A>